基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Luwor has almost two decades experience in using human cancer models and human patient samples to investigate the genetic and molecular alterations associated with cancer. Further to this Dr Luwor has expertise in developing molecular therapeutics for inhibition of tumour growth and progression.
In particular, Dr Luwor has performed pre-clinical, therapeutic evaluation of several agents designed to block tumour growth. More recently, Dr Luwor has expanded his research interests to explore tumour resistance to both molecular targeted therapy and standard chemotherapy.
In particular, Dr Luwor has performed pre-clinical, therapeutic evaluation of several agents designed to block tumour growth. More recently, Dr Luwor has expanded his research interests to explore tumour resistance to both molecular targeted therapy and standard chemotherapy.
Research Interests
Papers共 99 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MOLECULAR IMMUNOLOGY (2024): 101-109
Sarah F. Stuart, Peter Curpen, Adele J. Gomes, Michelle C. Lan,Shuai Nie,Nicholas A. Williamson,George Kannourakis,Andrew P. Morokoff,Adrian A. Achuthan,Rodney B. Luwor
Brain sciencesno. 1 (2024): 89
Integrative cancer therapies (2024): 15347354241243024-15347354241243024
Technology in cancer research & treatment (2024): 15330338241273160-15330338241273160
Cellsno. 2 (2024): 192
Load More
Author Statistics
#Papers: 103
#Citation: 4761
H-Index: 35
G-Index: 68
Sociability: 6
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn